Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Pfizer Inc (PFE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
How These Healthcare Stocks are Faring? -- Pfizer, Zoetis, Mallinckrodt, and Patheon

Stock-Callers.com revisits the Healthcare sector, which is an aggregation and integration of sectors within the economic system that provides goods and services to treat patients with curative, preventive,...

ZTS : 62.41 (+0.18%)
MNK : 41.08 (+2.09%)
PFE : 32.02 (-0.09%)
PTHN : 34.65 (-0.09%)
Pfizer Recommends Shareholders Reject the Below-Market Mini-Tender Offer by TRC Capital Corporation

Pfizer Inc. (NYSE:PFE) today announced that it has received notice of an unsolicited mini-tender offer by TRC Capital Corporation of Ontario, Canada to purchase up to 4 million shares of...

PFE : 32.02 (-0.09%)
Investors: Option reports for Citigroup, The Gap, Nike, NVIDIA and Pfizer Inc. include trade ideas that offer returns of 18% or more!

InvestorsObserver issues critical PriceWatch Alerts for C, GPS, NKE, NVDA, and PFE.

NVDA : 138.12 (-0.32%)
C : 62.53 (+0.42%)
NKE : 52.40 (+0.75%)
GPS : 22.44 (+1.13%)
PFE : 32.02 (-0.09%)
Shire (SHPG) Up on Positive Phase III Study Data on HAE Drug

Shire plc (SHPG) announced positive top-line results from the phase III study, HELP, on HAE candidate, lanadelumab.

AGLE : 4.85 (+2.11%)
VVUS : 1.11 (+0.91%)
SHPG : 184.89 (-0.25%)
PFE : 32.02 (-0.09%)
Merck's (MRK) Keytruda Gets FDA Nod for Two New Indications

Merck & Co., Inc. (MRK) announced that the FDA has approved two new indications for Keytruda (pembrolizumab), the company's anti-PD-1 therapy.

MRK : 64.72 (-0.32%)
AMGN : 155.01 (+0.27%)
PFE : 32.02 (-0.09%)
GSK : 42.66 (-0.68%)
Merck KGaA (MKGAF) Q1 Earnings Fall Y/Y, Revenues Increase

Merck KGaA (MKGAF) reported first-quarter 2017 earnings of $1.28 per American Depositary Share, 14.7% lower than the year-ago figure of $1.50.

RHHBY : 34.3100 (+0.26%)
PFE : 32.02 (-0.09%)
MKGAF : 116.8700 (-3.24%)
BMY : 54.01 (+0.35%)
Endocyte (ECYT) Focused on Two Lead Pipeline Candidates

We issued an updated report on Endocyte, Inc. (ECYT) on May 17.

AZN : 34.24 (-0.09%)
LLY : 78.04 (+0.10%)
ECYT : 2.51 (-0.40%)
PFE : 32.02 (-0.09%)
J&J (JNJ) Plans to Seek Approval for 10 New Drugs by 2021

Johnson & Johnson, Inc. (JNJ) discussed its future plans and showcased a strong pipeline of transformational medicines at a meeting held yesterday with industry analysts.

CATB : 1.35 (unch)
VVUS : 1.11 (+0.91%)
JNJ : 126.79 (-0.56%)
PFE : 32.02 (-0.09%)
The Zacks Analyst Blog Highlights: Pfizer, Home Depot, ConocoPhillips, Prudential Financial and Canadian Pacific

The Zacks Analyst Blog Highlights: Pfizer, Home Depot, ConocoPhillips, Prudential Financial and Canadian Pacific

PRU : 105.72 (+0.72%)
COP : 46.67 (+0.30%)
HD : 155.87 (+0.56%)
CP : 159.20 (+0.53%)
PFE : 32.02 (-0.09%)
The Lancet Publishes Phase 2 Results from Shire's Investigational Anti-MAdCAM Antibody Showing Significantly Increased Remission Rates in Patients with Moderate-to-Severe Ulcerative Colitis

DUBLIN, May 18, 2017 /PRNewswire/ --

SHPG : 184.89 (-0.25%)
PFE : 32.02 (-0.09%)
Sangamo's (SGMO) Hemophilia A Drug Gets Fast-Track Status

Sangamo Therapeutics, Inc. (SGMO) announced that the FDA has granted fast track designation to pipeline candidate, SB-525.

SGMO : 8.25 (+1.23%)
VVUS : 1.11 (+0.91%)
SHPG : 184.89 (-0.25%)
PFE : 32.02 (-0.09%)
Stock Market Today & Home Depot, Pfizer and ConocoPhillips Research Reports

Stock Market Today & Home Depot, Pfizer and ConocoPhillips Research Reports

COP : 46.67 (+0.30%)
HD : 155.87 (+0.56%)
CP : 159.20 (+0.53%)
PFE : 32.02 (-0.09%)
Pfizer Invites Public to View and Listen to Webcast of June 9 Conference Call with Analysts to Review Oncology Business and ASCO Data Presentations

Pfizer Inc. invites investors and the general public to view and listen to a webcast of a conference call with investment analysts on Friday, June 9, 2017 at 11:00 a.m. EDT. The purpose of...

PFE : 32.02 (-0.09%)
5 Reasons Why Merck (MRK) is a Good Stock to Buy Now

It looks like a great stock to buy now.

BAYRY : 130.8300 (-0.89%)
MRK : 64.72 (-0.32%)
LLY : 78.04 (+0.10%)
PFE : 32.02 (-0.09%)
Today's Research Reports on Stocks to Watch: BlackBerry and Pfizer

NEW YORK, NY / ACCESSWIRE / May 17, 2017 / Continued strength from the technology sector helped push the NASDAQ to a new record high. The NASDAQ has outperformed both the Dow Jones Industrial Average and...

BBRY : 11.32 (+2.07%)
PFE : 32.02 (-0.09%)
Aerie's (AERI) Rhopressa NDA Sufficient for FDA Review

Aerie Pharmaceuticals, Inc. (AERI) announced that it has received notification from the FDA about the completion of the initial 60-day review of the NDA for Rhopressa

AERI : 54.70 (+35.06%)
VVUS : 1.11 (+0.91%)
AGN : 224.65 (+0.22%)
PFE : 32.02 (-0.09%)
What happens to corporate crime cases with the FBI in flux?

WASHINGTON (AP) — There's the federal criminal investigation into Wells Fargo's opening of unauthorized client accounts.

WFC : 53.04 (-0.09%)
PFE : 32.02 (-0.09%)
What's in Store for Merck KGaA (MKGAF) in Q1 Earnings?

Merck KGaA (MKGAF) is scheduled to report first-quarter 2017 earnings results on May 18.

AZN : 34.24 (-0.09%)
EDIT : 16.75 (-2.73%)
PFE : 32.02 (-0.09%)
MKGAF : 116.8700 (-3.24%)
Pharma Stock Roundup: Mylan, Teva Q1 Earnings, Roche Drug Misses in Pivotal Study

While companies like Mylan (MYL), Allergan and Teva reported Q1 results this week, several companies provided updates on their cancer drugs.

MYL : 39.26 (+0.20%)
AZN : 34.24 (-0.09%)
JNJ : 126.79 (-0.56%)
MRK : 64.72 (-0.32%)
TEVA : 28.90 (-0.28%)
RHHBY : 34.3100 (+0.26%)
PFE : 32.02 (-0.09%)
Model N (MODN) Q2 Loss Narrower than Expected, Guides Well

Model N, Inc. (MODN) reported second-quarter 2017 adjusted loss of 25 cents per share, which was wider than the year-ago quarter's loss of 21 cents.

INTC : 36.33 (+0.58%)
JNJ : 126.79 (-0.56%)
MODN : 12.95 (+1.57%)
PFE : 32.02 (-0.09%)

Van Meerten Stock Picks

5 All Time High Large Caps for Momentum Investors
This morning I wanted to find 5 Large Caps that hit All Time Highs that might be of interest to Momentum Investors.
AON +0.43 , BAP -0.50 , BF.B -2.92 , VEEV +0.41 , ROL +0.34
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

Barchart Morning Call

OVERNIGHT MARKETS AND NEWS Jun E-mini S&Ps ( ESM17 +0.27%) this morning are up +0.27% at a new record nearest-futures high and extended Wednesday's rally after Wednesday afternoon's minutes of the May 2 -3 FOMC meeting indicated policy... Read More

Chart of the Day

Equinix (EQIX) is the Barchart Chart of the Day.  The computer building REIT has  Trend Spotter buy signal, a Weighted Alpha of 26.71 and gained 24.09% in the last year.
Read More

Brugler Ag Report

Today's Commentary

Corn futures are currently 1 to 1 ½ cents higher after closing 1 3/4 to 2 cents higher on Wednesday. The weekly EIA report in the morning had daily ethanol production at 1.01 million barrels per day last week. It showed ethanol production drop...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.